Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.1793 | 0.5 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.1793 | 0.5 | 0.5 |
Echinococcus multilocularis | indoleamine 2,3 dioxygenase 2 | 0.1793 | 0.5 | 0.5 |
Loa Loa (eye worm) | indoleamine 2,3-dioxygenase | 0.1793 | 0.5 | 0.5 |
Echinococcus granulosus | indoleamine 23 dioxygenase 2 | 0.1793 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 100 ug ml-1 | Antiinflammatory activity against TNF-alpha-induced ICAM1 protein expression in HUVEC pretreated for 2 hrs before TNFalpha challenge measured after 16 hrs by whole cell ELISA | ChEMBL. | 21955679 |
Inhibition (functional) | = 62 % | Antiinflammatory activity against TNF-alpha-induced ICAM1 protein expression in HUVEC at maximum tolerated dose pretreated for 2 hrs before TNFalpha challenge measured after 16 hrs by whole cell ELISA | ChEMBL. | 21955679 |
MTD (ADMET) | = 120 ug ml-1 | Cytotoxicity against HUVEC assessed as maximum tolerated dose for >95% cell viability after 24 hrs by MTT assay | ChEMBL. | 21955679 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.